Olga Pirogova Sells 548 Shares of Azenta, Inc. (NASDAQ:AZTA) Stock

Azenta, Inc. (NASDAQ:AZTAGet Free Report) SVP Olga Pirogova sold 548 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total transaction of $21,958.36. Following the completion of the sale, the senior vice president now directly owns 19,373 shares of the company’s stock, valued at $776,276.11. The trade was a 2.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Azenta Stock Down 0.8 %

Shares of AZTA opened at $45.16 on Friday. The stock’s 50 day moving average is $45.22 and its two-hundred day moving average is $50.12. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $69.16.

Azenta (NASDAQ:AZTAGet Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million during the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. Azenta’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.13 earnings per share. As a group, analysts anticipate that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.

Institutional Trading of Azenta

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP increased its holdings in Azenta by 16.5% in the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock valued at $156,331,000 after buying an additional 421,719 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Azenta by 16.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after acquiring an additional 183,040 shares during the period. Kayne Anderson Rudnick Investment Management LLC raised its holdings in Azenta by 1.9% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after purchasing an additional 100,826 shares during the last quarter. Squarepoint Ops LLC boosted its position in Azenta by 433.6% during the second quarter. Squarepoint Ops LLC now owns 73,055 shares of the company’s stock worth $3,844,000 after purchasing an additional 59,364 shares in the last quarter. Finally, Royce & Associates LP grew its holdings in Azenta by 7.8% in the third quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock valued at $35,844,000 after purchasing an additional 53,584 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on AZTA shares. Evercore ISI reduced their price objective on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Needham & Company LLC cut their price target on Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Azenta presently has an average rating of “Hold” and an average target price of $63.60.

View Our Latest Stock Analysis on Azenta

About Azenta

(Get Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Articles

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.